TransMedics Group

YTD

ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform.

CEO

Waleed H. Hassanein

CEOWaleed H. Hassanein

Employees

898

Employees898

Headquarters

Andover, Massachusetts

HeadquartersAndover, Massachusetts

Founded

1998

Founded1998

Employees

898

Employees898

TMDX Key Statistics

Market cap

2.19B

Market cap2.19B

Price-Earnings ratio

14.51

Price-Earnings ratio14.51

Dividend yield

—

Dividend yield—

Average volume

2.62M

Average volume2.62M

High today

$64.32

High today$64.32

Low today

$61.02

Low today$61.02

Open price

$61.72

Open price$61.72

Volume

1.22M

Volume1.22M

52 Week high

$156.00

52 Week high$156.00

52 Week low

$60.11

52 Week low$60.11

Stock Snapshot

The current TransMedics Group(TMDX) stock price is $63.23, with a market capitalization of 2.19B. The stock trades at a price-to-earnings (P/E) ratio of 14.51.

As of 2026-05-17, TransMedics Group(TMDX) stock has fluctuated between $61.02 and $64.32. The current price stands at $63.23, placing the stock +3.6% above today's low and -1.7% off the high.

TransMedics Group(TMDX) shares are trading with a volume of 1.22M, against a daily average of 2.62M.

During the past year, TransMedics Group(TMDX) stock moved between $60.11 at its lowest and $156.00 at its peak.

TMDX News

Simply Wall St 21h

Why TransMedics Group Is Down 6.8% After Mixed Q1 Results And Reaffirmed 2026 Guidance

In early May 2026, TransMedics Group reported first-quarter 2026 results showing revenue of US$173.93 million, up from US$143.54 million a year earlier, but net...

TipRanks 4d

Buy Rating Reaffirmed as Analyst Sees Upside Beyond Muted Q1 and Maintains $120 Price Target

TD Cowen analyst Josh Jennings maintained a Buy rating on TransMedics Group today and set a price target of $120.00. Claim 55% Off TipRanks Unlock hedge fund-le...

TipRanks 5d

TransMedics Buy Rating Reiterated as Analyst Sees Durable DCD-Driven Growth; $124 Price Target Maintained

Canaccord Genuity analyst William Plovanic maintained a Buy rating on TransMedics Group yesterday and set a price target of $124.00. Claim 55% Off TipRanks Unlo...

Analyst ratings

75%

of 12 ratings

Buy

75%

Hold

25%

Sell

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

MercadoLibre

Hims & Hers Health

Rocket Lab Corporation

ServiceNow

Trade Desk

SoFi Technologies

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.